Aptevo therapeutics inc

Major-Pharmaceuticals

APVO


2401 4th Avenue
Seattle , WA 98121

Executive/
Director

Price

  • Last Close
  • $ 0.13
    $ -0.01 -9.15 %
    Mar 5, 2024
  • 52-Week High/Low
  • $0.44 - $0.13
  • YTD
  • -28.7%

  • Trading Volume
  • 1,151,051
  • Market Cap Full
  • $ 2.3M
  • Shares Outstanding
  • 17.6M
    Nov 14, 2023
2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Q1 - - -15.6% -22.9% -29.1% -5% -16.7% -25.4% -12.1% -28.7%
Q2 - - 0.5% 57.9% -5.4% 4% -26.5% -39% -28.4% -
Q3 - -68% 10.6% -0.2% -33.4% 8% -31.2% -15.1% -77.4% -
Q4 - -4.7% 92.7% -74.3% 2% 372.3% -49% -23.7% -46.9% -
J F M A M J J A S O N D
2024 -9.9% 4.3% -24.1% - - - - - - - - -
2023 -0.9% -7.8% -3.8% -5.9% -18.8% -6.4% -28.8% -57.7% -25% -14.2% -33.9% -3.2%
    2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
    0%0%0%74%-70%-51%5802%-79%-71%-92%-29%

Earnings

2015 2016 2017 2018 2019 2020 2021 2022 2023
Q1 - - 0.48 -0.63 -0.44 0.89 -1.64 -1.55 0.39
Q2 - 0.63 0.53 -0.58 -0.3 -2.1 -1.75 5.58 -1.23
Q3 - 0.80 0.14 -0.56 -0.16 -2.1 -1.43 -1.5 -0.50
Q4 - 0.01 - -0.62 0.06 -1.92 -1.25 -0.96 -
A 0 1.4 1.2 -2.4 -0.8 -5.2 -6.1 1.6 -1.34

Annual Returns

52 Week
High/Low

Annual
Earnings

Chart

Trading Volume

2018 2019 2020 2021 2022 2023
Mar - 42.9 45.3 4.4 5 7.2
Jun 22.6 45.1 3.2 4.4 5 7.3
Sep 22.7 45.1 3.2 4.9 5.1 11.5
Dec 22.7 45.3 4.1 4.9 5.1 17.6

Financial Ratios

20222021202020192018
Asset Management
Inventory / Stock Turnover - - - 3.3 5.5
Fixed Asset Turnover 3 6 1 2.1 1.8
Total Asset Turnover 0.1 0.2 0.1 0.6 0.3
Leverage
Debt Ratio - 0.1 0.4 - 0.4
Debt – Equity Ratio 0.1 4 1.2 - 0.6
Interest Coverage 0.8 -3 3 14.3 -26
Equity multiplier 0.1 2 0.2 1.3 0.4